Vertex Announces European Commission Approval for Kalydeco® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Vertex 宣布欧盟委员会批准 Kalydeco® 用于治疗 1 个月及以上的囊性纤维化婴儿
Vertex Announces European Commission Approval for Kalydeco® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older
Vertex 宣布欧盟委员会批准 Kalydeco® 用于治疗 1 个月及以上的囊性纤维化婴儿
使用浏览器的分享功能,分享给你的好友吧